| Dr James L Bowers, DO | |
|
1415 E Scott St, Kirksville, MO 63501-3868 | |
| (660) 665-1767 | |
| (660) 665-1767 |
| Full Name | Dr James L Bowers |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1415 E Scott St, Kirksville, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063493799 | NPI | - | NPPES |
| 3978 | Other | MO | BNDD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R8552 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James L Bowers, DO 1415 E Scott St, Kirksville, MO 63501-3868 Ph: (660) 665-1767 | Dr James L Bowers, DO 1415 E Scott St, Kirksville, MO 63501-3868 Ph: (660) 665-1767 |
News Archive
With the four-year anniversary of Haiti's devastating, 7.0 magnitude earthquake just two weeks away, Mission of Hope a Christian nonprofit headquartered in Haiti, has developed a holistic model for long-term development and rebuilding that works and is sustainable.
Protein fragments, called amyloid fibrils, in human semen significantly increase Ebola virus infection and protect the virus against harsh environmental conditions such as heat and dehydration. Researchers from the Perelman School of Medicine at the University of Pennsylvania report these findings in a study published this week in the Proceedings of the National Academy of Sciences.
Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avastin.
Vanda Pharmaceuticals Inc. today announced its plans to initiate a Phase IIb/III clinical trial of tasimelteon in patients with Major Depressive Disorder (MDD). The trial is expected to begin during the second half of 2011. Tasimelteon is currently being evaluated in Phase III clinical trials for the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals without light perception.
› Verified 3 days ago
Karen A Sylvara, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 S Baltimore St, Kirksville, MO 63501 Phone: 660-665-5570 Fax: 660-665-2898 | |
Dr. Katherine Lynne Holbrook, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 800 W Jefferson St, Kirksville, MO 63501 Phone: 660-626-2223 | |
Molly Christine Thompson, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 | |
Dr. Stephanie Gonzales, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 | |
Dr. Ronald Leland Phillips, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Crown Dr, Suite 200, Kirksville, MO 63501 Phone: 660-665-3838 Fax: 660-665-0130 | |
Dr. Steven R Lyons, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Jefferson St, Kirksville, MO 63501 Phone: 660-785-1000 |